keyword
https://read.qxmd.com/read/38319942/impact-of-interstitial-lung-disease-on-left-ventricular-myocardial-function
#21
JOURNAL ARTICLE
Max Jonathan Stumpf, Marina Michaela Luise Wirtz, Max Fabian Fleddermann, Leonie Biener, Leonie Weinhold, Marcel Weber, Christian Alexander Schaefer, Georg Nickenig, Dirk Skowasch, Carmen Pizarro
BACKGROUND: Interstitial lung disease (ILD) comprises a wide variety of pulmonary parenchymal disorders within which progressive fibrosing ILD (PF-ILD) constitutes a phenotypic subset. By use of speckle tracking-based strain analysis we aimed to evaluate the degree of left ventricular (LV) dysfunction in progressive vs. non-progressive fibrosing ILD (non-PF-ILD). METHODS: A total of 99 ILD patients (mean age 63.7 ± 13.5 years, 37.4% female), composed of 50 PF-ILD and 49 non-PF-ILD patients, and 33 controls were prospectively enrolled and underwent conventional and speckle tracking echocardiography...
2024: PloS One
https://read.qxmd.com/read/38289091/estimating-the-effect-of-nintedanib-on-forced-vital-capacity-in-children-and-adolescents-with-fibrosing-interstitial-lung-disease-using-a-bayesian-dynamic-borrowing-approach
#22
JOURNAL ARTICLE
Toby M Maher, Kevin K Brown, Steven Cunningham, Emily M DeBoer, Robin Deterding, Elizabeth K Fiorino, Matthias Griese, Nicolaus Schwerk, David Warburton, Lisa R Young, Martina Gahlemann, Florian Voss, Christian Stock
BACKGROUND: The rarity of childhood interstitial lung disease (chILD) makes it challenging to conduct powered trials. In the InPedILD trial, among 39 children and adolescents with fibrosing ILD, there was a numerical benefit of nintedanib versus placebo on change in forced vital capacity (FVC) over 24 weeks (difference in mean change in FVC % predicted of 1.21 [95% confidence interval: -3.40, 5.81]). Nintedanib has shown a consistent effect on FVC across populations of adults with different diagnoses of fibrosing ILD...
January 30, 2024: Pediatric Pulmonology
https://read.qxmd.com/read/38256318/unmasking-a-silent-threat-improving-pulmonary-hypertension-screening-methods-for-interstitial-lung-disease-patients
#23
REVIEW
Vaida Averjanovaitė, Lina Gumbienė, Ingrida Zeleckienė, Virginija Šileikienė
This article provides a comprehensive overview of the latest literature on the diagnostics and treatment of pulmonary hypertension (PH) associated with interstitial lung disease (ILD). Heightened suspicion for PH arises when the advancement of dyspnoea in ILD patients diverges from the expected pattern of decline in pulmonary function parameters. The complexity of PH associated with ILD (PH-ILD) diagnostics is emphasized by the limitations of transthoracic echocardiography in the ILD population, necessitating the exploration of alternative diagnostic approaches...
December 28, 2023: Medicina
https://read.qxmd.com/read/38206760/the-digital-1-minute-walk-test-a-new-patient-centered-cardiorespiratory-endpoint
#24
JOURNAL ARTICLE
Lucy Robertson, Joseph Newman, Shaun Clayton, Mary Ferguson, Joanna Pepke-Zaba, John Cannon, Karen Sheares, Dolores Taboada, Katherine Bunclark, Iain Armstrong, Elisa Ferrer Mallol, Elin Haf Davies, Mark Toshner
No abstract text is available yet for this article.
January 11, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38205098/pulmonary-hypertension-in-the-setting-of-interstitial-lung-disease-approach-to-management%C3%A2-and-treatment-a-consensus-statement-from-the-pulmonary-vascular-research-institute-s-innovative-drug-development-initiative-group-3-pulmonary-hypertension
#25
REVIEW
Oksana A Shlobin, Eric Shen, Stephen J Wort, Lucilla Piccari, John A Scandurra, Paul M Hassoun, Sylvia M Nikkho, Steven D Nathan
Pulmonary hypertension (PH) due to interstitial lung disease (ILD), a commonly encountered complication of fibrotic ILDs, is associated with significant morbidity and mortality. Until recently, the studies of pulmonary vasodilator therapy in PH-ILD have been largely disappointing, with some even demonstrating the potential for harm. This paper is part of a series of Consensus Statements from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative for Group 3 Pulmonary Hypertension, with prior publications covering pathogenesis, prevalence, clinical features, phenotyping, clinical trials, and impact of PH-ILD...
January 2024: Pulmonary Circulation
https://read.qxmd.com/read/38202239/the-role-of-high-flow-nasal-cannula-oxygen-therapy-in-exercise-testing-and-pulmonary-rehabilitation-a-review-of-the-current-literature
#26
REVIEW
Claudio Candia, Carmen Lombardi, Claudia Merola, Pasquale Ambrosino, Silvestro Ennio D'Anna, Aldo Vicario, Stefania De Marco, Antonio Molino, Mauro Maniscalco
High-flow nasal cannula (HFNC) has recently emerged as a crucial therapeutic strategy for hypoxemic patients both in acute and chronic settings. Indeed, HFNC therapy is able to deliver higher fractions of inspired oxygen (FiO2 ) with a heated and humidified gas flow ranging from 20 up to 60 L per minute, in a more comfortable way for the patient in comparison with Conventional Oxygen Therapy (COT). In fact, the flow keeps the epithelium of the airways adequately moisturized, thus positively affecting the mucus clearance...
December 30, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/38193770/moderate-exercise-modulates-inflammatory-responses-and-improves-survival-in-a-murine-model-of-acute-pneumonia
#27
JOURNAL ARTICLE
Veronique Vermeersch, Karelle Léon, Anais Caillard, Amandine Szczesnowski, Gaëlle Albacete, Nadege Marec, Florine Tissier, Guillaume Gilbert, Mickael Droguet, Pascale Marcorelles, Marie-Agnes Giroux-Metges, Olivier Huet
OBJECTIVES: An association between physical inactivity and worse outcome during infectious disease has been reported. The effect of moderate exercise preconditioning on the immune response during an acute pneumonia in a murine model was evaluated. SETTING: Laboratory experiments. SUBJECTS: C57BL6/j male mice. INTERVENTIONS: Six-week-old C57BL/6J mice were divided in two groups: an exercise group and a control group. In the exercise group, a moderate, progressive, and standardized physical exercise was applied for 8 weeks...
March 1, 2024: Critical Care Medicine
https://read.qxmd.com/read/38188134/assessment-of-the-feasibility-of-1-min-sit-to-stand-test-in-evaluating-functional-exercise-capacity-in-interstitial-lung-disease-patients
#28
JOURNAL ARTICLE
Ravi Singh, Deepak Aggarwal, Kashish Dutta, Surabhi Jaggi, Mandeep Kaur Sodhi, Varinder Saini
Six-min walk test (6MWT) is widely used exercise test for the evaluation of interstitial lung disease (ILD). However, the long test duration and need for long and flat surface hinder its routine use. One-min sit-to-stand test (1-STST) is devoid of such limitations, but has been scarcely evaluated. The study was conducted to evaluate the performance of 1-STST by correlating it with 6MWT in ILD patients. Stable ILD patients were prospectively enrolled. After initial spirometry, all patients performed 6MWT and 1-STST following the standard recommendations...
December 2023: Journal of Exercise Rehabilitation
https://read.qxmd.com/read/38068366/clinical-characteristics-of-individuals-with-interstitial-lung-diseases-and-indication-of-end-of-life-care
#29
JOURNAL ARTICLE
Gabriela Krinski, Larissa Dragonetti Bertin, Heloise Angélico Pimpão, Humberto Silva, Brunna Luiza Tavares, Leonardo Lunardelli, Geovana Alves do Prado, Fabio Pitta, Carlos Augusto Camillo
End-of-life care (EOLC) is palliative support provided in the last 6 months to 1 year of a patient's life. Although there are established criteria for its indication, few studies describe the clinical and functional characteristics of individuals with interstitial lung diseases (ILD) in EOLC. ILD individuals underwent various assessments, including lung function, exercise capacity (6 min walk test), physical activity in daily life (PADL), peripheral muscle strength, maximal respiratory pressures, body composition, quality of life (SGRQ-I), symptoms of anxiety and depression, dyspnea (MRC scale), and sleep quality...
November 25, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/38032699/the-utility-of-a-novel-electrocardiogram-patch-using-dry-electrodes-technology-for-arrhythmia-detection-during-exercise-and-prolonged-monitoring-proof-of-concept-study
#30
JOURNAL ARTICLE
Lonneke A Fruytier, Daan M Janssen, Israel Campero Jurado, Danny Ajp van de Sande, Ilde Lorato, Shavini Stuart, Pradeep Panditha, Margreet de Kok, Hareld Mc Kemps
BACKGROUND: Accurate detection of myocardial ischemia and arrhythmias during free-living exercise could play a pivotal role in screening and monitoring for the prevention of exercise-related cardiovascular events in high-risk populations. Although remote electrocardiogram (ECG) solutions are emerging rapidly, existing technology is neither designed nor validated for continuous use during vigorous exercise. OBJECTIVE: In this proof-of-concept study, we evaluated the usability, signal quality, and accuracy for arrhythmia detection of a single-lead ECG patch platform featuring self-adhesive dry electrode technology in individuals with chronic coronary syndrome...
November 30, 2023: JMIR Formative Research
https://read.qxmd.com/read/37993385/differential-diagnosis-of-igg4-positive-plasma-cells-in-the-lung
#31
REVIEW
Sanjay Mukhopadhyay
The recognition of immunoglobulin G4-related disease (IgG4-RD) as an entity in the pancreaticobiliary tract was followed by a slew of papers describing inflammation and fibrosis containing IgG4-positive plasma cells in a variety of sites including the respiratory tract, leading to the hypothesis that these abnormalities were attributable to IgG4-RD. Predictably, pathologists began to see requests from clinicians to perform IgG4 immunohistochemistry in lung biopsies "to rule out IgG4-RD". Several years later, the notion that IgG4-RD would prove to be the underlying cause of a wide array of fibroinflammatory lesions in the lung has not panned out as promised...
March 2024: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37941096/impact-of-test-instructions-on-6-min-walk-distance-in-adults-with-chronic-respiratory-disease-a-randomized-controlled-trial
#32
JOURNAL ARTICLE
Christie R Mellerick, Angela T Burge, Catherine J Hill, Narelle S Cox, Janet Bondarenko, Anne E Holland
PURPOSE: The 6-min walk test (6MWT) is commonly used to assess functional exercise capacity in people with chronic respiratory disease in both clinical and research settings. However, two tests are required to achieve accurate results, due to a well-documented learning effect for the 6-min walk distance (6MWD). Whether it is possible to reduce or eliminate the learning effect by optimizing 6MWT instructions is not known. METHODS: People with chronic respiratory disease referred to pulmonary rehabilitation undertook two 6MWT with random allocation to modified instructions (fast-walk as fast as possible; n = 46) or usual instructions (far-walk as far as possible; n = 49)...
November 8, 2023: Journal of Cardiopulmonary Rehabilitation and Prevention
https://read.qxmd.com/read/37933757/translation-cross-cultural-adaptation-reliability-and-construct-validity-of-the-brazilian-portuguese-version-of-the-basic-psychological-needs-in-exercise-scale
#33
JOURNAL ARTICLE
Manuela Karloh, Simone G Gavenda, Juliana Araújo, Hellen F Alexandre, Isabela Jcs Silva, Aline A Gulart, Anelise B Munari, Symeon P Vlachopoulos, Thiago S Matias, Anamaria F Mayer
59 patients were included (61% with COPD and 39% with ILD). BPNES factor scores were not significantly different between raters' assessments ( p > 0.05). The internal consistency was 0.70 for autonomy, 0.76 for competence, and 0.80 for relatedness. Inter-rater and test-retest reliability were good to very good for autonomy (ICC = 0.78, 95%CI 0.62-0.87; ICC = 0.75, 95%CI 0.57-0.86, respectively), competence (ICC = 0.81, 95%CI 0.68-0.89; ICC = 0.65, 95%CI 0.43-0.80, respectively), and relatedness (ICC = 0...
2023: Chronic Respiratory Disease
https://read.qxmd.com/read/37928415/improvement-in-the-clinical-manifestations-of-interstitial-lung-disease-following-treatment-with-placental-mesenchymal-stromal-cell-extracellular-vesicles-in-a-patient-with-systemic-sclerosis-a-case-report
#34
Shirin Assar, Dena Mohammadzadeh, Amir Hossein Norooznezhad, Mehrdad Payandeh, Daryoush Hassaninia, Mehran Pournazari, Parviz Soufivand, Reza Yarani, Kamran Mansouri
BACKGROUND: Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient with ILD due to SSc. CASE PRESENTATION: The patient was a 55-year-old woman with a ten years history of SSc complicated by severe ILD. Over time, her lung disease progressed to interstitial fibrosis despite being treated with mycophenolate mofetil and monthly pulses of cyclophosphamide...
2023: Respiratory Medicine Case Reports
https://read.qxmd.com/read/37925418/plasma-metabolomics-and-quantitative-interstitial-abnormalities-in-ever-smokers
#35
JOURNAL ARTICLE
Bina Choi, Raúl San José Estépar, Suneeta Godbole, Jeffrey L Curtis, Jennifer M Wang, Rubén San José Estépar, Ivan O Rosas, Jared R Mayers, Brian D Hobbs, Craig P Hersh, Samuel Y Ash, MeiLan K Han, Russell P Bowler, Kathleen A Stringer, George R Washko, Wassim W Labaki
BACKGROUND: Quantitative interstitial abnormalities (QIA) are an automated computed tomography (CT) finding of early parenchymal lung disease, associated with worse lung function, reduced exercise capacity, increased respiratory symptoms, and death. The metabolomic perturbations associated with QIA are not well known. We sought to identify plasma metabolites associated with QIA in smokers. We also sought to identify shared and differentiating metabolomics features between QIA and emphysema, another smoking-related advanced radiographic abnormality...
November 4, 2023: Respiratory Research
https://read.qxmd.com/read/37847730/five-repetition-sit-to-stand-test-responsiveness-and-minimal-important-difference-in-idiopathic-pulmonary-fibrosis
#36
JOURNAL ARTICLE
Puja Trivedi, Suhani Patel, George Edwards, Timothy Jenkins, William D-C Man, Claire M Nolan
RATIONALE: Standing from a sitting position is an important activity of daily living. The five-repetition sit-to-stand test (5STS) is a simple physical performance test that measures the fastest time taken to stand five times from a chair with arms folded. It can be measured in most healthcare settings, including the home where traditional field walking tests may not be possible. The 5STS has been validated in community-dwelling older adults and people with COPD, but data in idiopathic pulmonary fibrosis (IPF) are limited...
October 17, 2023: Annals of the American Thoracic Society
https://read.qxmd.com/read/37823221/resolvin-d1-improves-airway-inflammation-and-exercise-capacity-in-cystic-fibrosis-lung-disease
#37
JOURNAL ARTICLE
Giulia Ferri, Matteo Serano, Elisa Isopi, Matteo Mucci, Domenico Mattoscio, Romina Pecce, Feliciano Protasi, Marcus A Mall, Mario Romano, Antonio Recchiuti
Mucus plugging and non-resolving inflammation are inherent features of cystic fibrosis (CF) that may lead to progressive lung disease and exercise intolerance, which are the main causes of morbidity and mortality for people with CF. Therefore, understanding the influence of mucus on basic mechanisms underlying the inflammatory response and identifying strategies to resolve mucus-driven airway inflammation and consequent morbidity in CF are of wide interest. Here, we investigated the effects of the proresolving lipid mediator resolvin (Rv) D1 on mucus-related inflammation as a proof-of-concept to alleviate the burden of lung disease and restore exercise intolerance in CF...
November 2023: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology
https://read.qxmd.com/read/37787356/impact-of-hrct-pattern-on-six-minute-walk-test-in-patients-with-interstitial-lung-disease-an-observational-study
#38
JOURNAL ARTICLE
Puneet Saxena, Itishree Singh, Abhishek Kumar, S Kartik, Virender Malik, Saurabh Tiwari, K R Akhil, Somali Pattanayak, Vaibhavi G Velangi, Harsh Jain
BACKGROUND: Forced vital capacity (FVC) and six-minute walk distance (6MWD) are robust markers in interstitial lung diseases (ILD) to assess severity and prognosis. It is unknown whether high-resolution computed tomography pattern has any independent effect on the exercise capacity in ILD. We compared six-minute walk test (6MWT) parameters between usual interstitial pneumonia (UIP) and non-UIP ILD after adjusting for FVC. METHODS: Data from a tertiary care ILD clinic were retrospectively analysed...
2023: Lung India: Official Organ of Indian Chest Society
https://read.qxmd.com/read/37725867/reference-value-for-the-6-min-walking-distance-in-women-with-systemic-sclerosis-considering-the-impact-of-muscle-strength
#39
JOURNAL ARTICLE
Nathália Alves de Oliveira Saraiva, Iasmim de Oliveira Farias, Brenda Mesquita Dos Santos, Rosemere Saldanha Xavier, Agnaldo José Lopes
BACKGROUND: Early triage, the search for new therapies, and closer monitoring of patients with systemic sclerosis before their lung function irreversibly deteriorates are urgent concerns. Because it is an independent predictor of systemic sclerosis-related mortality, the 6-min walk test is a potentially useful tool to evaluate outcomes, along with pulmonary function and computed tomography. This study aimed to establish a reference value for the 6-min walking distance in women with diffuse cutaneous systemic sclerosis-associated interstitial lung disease that takes into account the effects of muscle and lung function...
September 15, 2023: Clinical Biomechanics
https://read.qxmd.com/read/37706024/inhaled-therapies-targeting-prostacyclin-pathway-in-pulmonary-hypertension-due-to-copd-systematic-review
#40
REVIEW
Abdullah A Alqarni, Abdulelah M Aldhahir, Heba M Bintalib, Jaber S Alqahtani, Rayan A Siraj, Mansour Majrshi, Abdulkareem A AlGarni, Abdallah Y Naser, Sara A Alghamdi, Hassan Alwafi
BACKGROUND: Pulmonary hypertension due to chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) is classified as group 3 pulmonary hypertension. Inhaled treprostinil, a prostaglandin I2 analogue also known as prostacyclin, has recently been approved as a first drug for patients with pulmonary hypertension secondary to ILD. However, due to a lack of evidence, no therapies are currently approved for those with COPD-associated pulmonary hypertension. Thus, this systematic review aims to summarise the current evidence to assess the impact of inhaled prostaglandin I2 analogue use on the pulmonary hemodynamics, exercise function, lung function, and gas exchange in patients with pulmonary hypertension due to COPD...
2023: Frontiers in Medicine
keyword
keyword
84608
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.